Precision BioSciences Inc. share price logo

Precision BioSciences Inc.

NASDAQ: DTIL

Small Cap

$6.81

+0.31

(+4.77%)

as on

Precision BioSciences Inc. Stock Performance

as on June 19, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $6.51
    $6.98
    downward going graph

    4.41%

    Downside

    2.50%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.53
    $8.82
    downward going graph

    48.16%

    Downside

    29.52%

    Upside

    downward going graph

Precision BioSciences Inc. share price movements today

Previous Close
$6.50
Open
$6.70
Volume
272.4K
Day's Low - High
$6.51 - $6.98
52 Week Low - High
$3.53 - $8.82

Precision BioSciences Inc. Historical Returns

1 Month Return
-1.3 %
3 Month Return
+ 1.34 %
1 Year Return
+ 44.89 %
3 Year Return
-65.61 %
5 Year Return
-97.84 %

Precision BioSciences Inc. Stock Fundamentals & Key Indicators

Check Precision BioSciences Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$175.7M

EPS (TTM)

-2.4867

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-37.7M

Revenue (TTM)

45.1M

Profit Margin

-96.73%

Return On Equity TTM

-70.93%

Precision BioSciences Inc. stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Precision BioSciences Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Precision BioSciences Inc. image
Precision BioSciences Inc.
BUY$175.7M-97.84%NA-96.73%NA

Stock Returns calculator for Precision BioSciences Inc. Stock including INR - Dollar returns

The Precision BioSciences Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Precision BioSciences Inc. investment value today

Current value as on today

₹1,57,830

Returns

₹57,830

(+57.83%)

Returns from Precision BioSciences Inc. Stock

₹44,894 (+44.89%)

Dollar Impact

₹12,936 (+12.94%)

Analyst Recommendation on Precision BioSciences Inc. Stock

Based on 12 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 12 analysts, 83.33% of analysts recommend a 'BUY' rating for Precision BioSciences Inc.. Average target price of $29.6

Precision BioSciences Inc. Share Price Target

Get share price movements and forecasts by analysts on Precision BioSciences Inc..

What analysts predicted

76.99%UPSIDE

Target Price

$29.6

Current Price

$6.81

Analyzed by

12 Analysts

Target

$29.60

Precision BioSciences Inc. target price $29.6, a slight upside of 76.99% compared to current price of $6.81. According to 12 analysts rating.

Indian Investors' Interest in Precision BioSciences Inc. Stock

Search interest for Precision BioSciences Inc. Stock has increased by 76% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:76% versus previous 30 day period

Precision BioSciences Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
7
17
49
0
0
0
0
0
34
10
Gross Profit
7
17
49
0
0
0
0
0
33
10
Operating Income
-14
-4
24
-21
-24
-22
-21
-20
12
-9
EBITDA
-11
10
34
-15
-16
-19
-22
-20
20
-17
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
1
1
1
1
0
0
0
0
0
0
Income Before Tax
-13
8
32
-16
-17
-20
-23
-21
19
-18
Income Tax Expense
2
1
-1
3
0
-
-
-
-
-
Net Income
-16
8
32
-16
-17
-20
-23
-21
19
-18
Net Profit Margin
-231.44%
48.84%
65.63%
-2851.56%
-2781.35%
-70913.79%
-130666.67%
-167476.92%
56.27%
-170.15%

Precision BioSciences Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
7
6
10
22
24
115
25
48
68
34
Gross Profit
7
6
10
22
24
115
25
48
68
31
Operating Income
-8
-21
-47
-87
-109
-39
-62
-43
-26
-52
EBITDA
-8
-20
-43
-87
-99
-20
-62
-32
13
-42
Interest Expense
-
-
-
0
0
0
1
2
1
1
Depreciation
-
1
2
5
9
10
9
8
4
2
Income Before Tax
-8
-21
-46
-92
-109
-30
-72
-42
7
-46
Income Tax Expense
0
0
1
-9
10
0
11
27
-
-
Net Income
-8
-21
-46
-92
-109
-30
-111
-61
7
-46
Net Profit Margin
-117.62%
-325.45%
-423.02%
-417.65%
-448.86%
-26.49%
-444.80%
-125.84%
10.43%
-136.03%

Precision BioSciences Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
8
32
-16
-17
-20
-23
-21
20
-18
Operating Cash Flow
-18
-14
-5
-18
-19
-20
-15
-11
-11
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
40
0
3
5
10
5
1
77
0
Change in Cash
21
-14
-2
-12
-8
-14
-17
65
-11

Precision BioSciences Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-21
-46
-92
-109
-30
-111
-61
7
-45
Operating Cash Flow
-24
-51
-73
-87
-10
-45
-84
-58
-65
Investing Cash Flow
-5
-15
-24
-5
-5
-3
5
0
0
Financing Cash Flow
0
107
175
1
70
94
5
50
95
Change in Cash
-30
40
77
-91
53
45
-72
-8
28

Global Institutional Holdings in Precision BioSciences Inc.

Funds
Holdings
Two Sigma Investments LLC
1.19%
TANG CAPITAL MANAGEMENT LLC
2.71%
Geode Capital Management, LLC
1.11%
BlackRock Inc
0.77%
State Street Corp
0.22%
See all

Precision BioSciences Inc. News & Key Events

  • img

    Today's Timeline - 11 March

    Wed, 04:32 PM

    -

    Precision BioSciences receives two U.S. patent allowances for PBGENE-HBV program, enhancing intellectual property protection.

Insights on Precision BioSciences Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, DTIL stock has moved up by 11.6%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, DTIL has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Retail Holding Unchanged

    img

    Retail Investor holdings remained unchanged at 29.11% of holdings in Mar 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Avanti Feeds Ltd has given 149.2% return, outperforming this stock by 181.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Avanti Feeds Ltd has given 33.9% return, outperforming this stock by 61.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Precision BioSciences, Inc. Common Stock has experienced a drawdown of -65.1%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 43.2%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 68.90% of holdings in Mar 2026 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 34.20M → 10.83M (in $), with an average decrease of 68.3% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 21.16 Cr → -30.9 Cr (in ₹), with an average decrease of 233.8% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 19.24M → -18.44M (in $), with an average decrease of 195.8% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, DTIL stock has moved down by -32.7%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 173.52 Cr → 83.93 Cr (in ₹), with an average decrease of 29.4% per quarter

About Precision BioSciences Inc.

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-DMD (Excision) for the treatment of Duchenne muscular dystrophy. In addition, the company develops PBGENE-3243 for the treatment of m.3243 associated mitochondrial diseases; and iECURE-OTC (Insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with TG Cell Therapy, Inc. to develop, manufacture, and commercialize azercabtagene zapreleucel for autoimmune diseases and other indications; and iECURE, Inc., an ARCUS-mediated targeted gene insertion. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.
OrganisationPrecision BioSciences Inc.
Headquarters302 East Pettigrew St., Durham, NC, United States, 27701
IndustryBiotechnology
CEOMr. Michael Amoroso
E-voting on sharesClick here to vote

Key Management of Precision BioSciences Inc.

Name

Title

Mr. John Alexander Kelly R.Ph.

CFO & Principal Accounting Officer

Mr. Dario Scimeca J.D.

General Counsel & Secretary

Dr. Jefferson J. Smith Ph.D.

Co-Founder & Chief Research Officer

Mr. Naresh Tanna

Chief of Staff to CEO & Head of Investor Relations

Ms. Cindy Atwell

Chief Development & Business Officer

Mr. Michael Amoroso

President, CEO & Director

Dr. Cassie Gorsuch Ph.D.

Chief Scientific Officer

Ms. Juli Blanche

Chief People Officer

Mr. Neil Leatherbury M.S.

Senior VP and Head of Chemistry, Manufacturing & Controls

FAQs

What is Precision BioSciences Inc. share price today?

Precision BioSciences Inc. share price today is $6.81 as on at the close of the market. Precision BioSciences Inc. share today touched a day high of $6.98 and a low of $6.51.

What is the 52 week high and 52 week low for Precision BioSciences Inc. share?

Precision BioSciences Inc. share touched a 52 week high of $8.82 on and a 52 week low of $3.53 on . Precision BioSciences Inc. stock price today i.e. is closed at $6.81,which is 22.79% down from its 52 week high and 92.92% up from its 52 week low.

What is Precision BioSciences Inc.'s market capitalisation today?

Precision BioSciences Inc. market capitalisation is $0.00T as on .

How to invest in Precision BioSciences Inc. Stock (DTIL) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Precision BioSciences Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Precision BioSciences Inc. Shares that will get you 0.2203 shares as per Precision BioSciences Inc. share price of $6.81 per share as on June 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Precision BioSciences Inc. Stock (DTIL) from India?

Indian investors can start investing in Precision BioSciences Inc. (DTIL) shares with as little as ₹94.31 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹943.10 in Precision BioSciences Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Precision BioSciences Inc. share’s latest price of $6.81 as on June 19, 2026 at 8:46 am IST, you will get 1.4684 shares of Precision BioSciences Inc.. Learn more about fractional shares .

What are the returns that Precision BioSciences Inc. has given to Indian investors in the last 5 years?

Precision BioSciences Inc. stock has given -97.84% share price returns and 27.5% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?